Yabao Pharmaceutical Group Co Ltd Cash Flow Quality Index
Yabao Pharmaceutical Group Co Ltd cash flow quality index. Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Quality Index of 3.18x as of September 2025. Operating cash flow of CN¥129.49 Million exceeds net income of CN¥40.70 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Yabao Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Yabao Pharmaceutical Group Co Ltd (2001–2024)
Cash flow quality index of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. Historical Cash Flow Quality Index for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600351 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Yabao Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (2001–2024)
Yabao Pharmaceutical Group Co Ltd cash flow quality index by year from 2001 to 2024. Year-by-year earnings quality comparison for Yabao Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Yabao Pharmaceutical Group Co Ltd (600351) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥471.69 Million | CN¥223.92 Million | ▼ -15.5% |
| 2023 | 2.49x | CN¥497.55 Million | CN¥199.59 Million | ▼ -43.4% |
| 2022 | 4.40x | CN¥460.46 Million | CN¥104.60 Million | ▲ +84.9% |
| 2021 | 2.38x | CN¥437.50 Million | CN¥183.76 Million | ▼ -31.9% |
| 2020 | 3.50x | CN¥380.96 Million | CN¥108.99 Million | ▼ -91.1% |
| 2019 | 39.37x | CN¥425.17 Million | CN¥10.80 Million | ▲ +2521.3% |
| 2018 | 1.50x | CN¥426.60 Million | CN¥284.02 Million | ▲ +85.6% |
| 2017 | 0.81x | CN¥161.73 Million | CN¥199.82 Million | ▼ -86.0% |
| 2016 | 5.77x | CN¥155.95 Million | CN¥27.04 Million | ▲ +776.6% |
| 2015 | 0.66x | CN¥143.47 Million | CN¥218.05 Million | ▼ -39.2% |
| 2014 | 1.08x | CN¥178.63 Million | CN¥165.11 Million | ▲ +115.7% |
| 2013 | 0.50x | CN¥56.80 Million | CN¥113.26 Million | ▲ +157.0% |
| 2012 | -0.88x | CN¥-96.73 Million | CN¥109.87 Million | ▼ -526.8% |
| 2011 | 0.21x | CN¥40.73 Million | CN¥197.41 Million | ▲ +54.9% |
| 2010 | 0.13x | CN¥18.57 Million | CN¥139.40 Million | ▼ -95.4% |
| 2009 | 2.88x | CN¥368.56 Million | CN¥128.16 Million | ▲ +142.5% |
| 2008 | 1.19x | CN¥102.90 Million | CN¥86.76 Million | ▼ -46.2% |
| 2007 | 2.20x | CN¥105.69 Million | CN¥47.95 Million | ▲ +169.6% |
| 2006 | 0.82x | CN¥11.59 Million | CN¥14.18 Million | ▼ -47.7% |
| 2005 | 1.56x | CN¥26.40 Million | CN¥16.88 Million | ▼ -34.0% |
| 2004 | 2.37x | CN¥79.73 Million | CN¥33.63 Million | ▲ +708.2% |
| 2003 | -0.39x | CN¥-9.62 Million | CN¥24.68 Million | ▼ -132.0% |
| 2002 | 1.22x | CN¥24.29 Million | CN¥19.94 Million | ▼ -5.7% |
| 2001 | 1.29x | CN¥23.59 Million | CN¥18.26 Million | — |